Prediction methods of drug-drug interactions of non-oral CYP3A4 substrates based on clinical interaction data after oral administrations – Validation with midazolam, alfentanil, and verapamil after intravenous administration and prediction for blonanserin transdermal patch-Reference-Cited by-同舟云学术

Prediction methods of drug-drug interactions of non-oral CYP3A4 substrates based on clinical interaction data after oral administrations – Validation with midazolam, alfentanil, and verapamil after intravenous administration and prediction for blonanserin transdermal patch

Published:2020-08 Issue:4 Volume:35 Page:345-353
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Tomita Yoshiko,Yahata Masahiro,Hashimoto Masayo,Nishimuta Haruka,Kawaguchi Hiroko,Matsushita Hidenori,Kitamura Atsushi,Nishibe Hironori,Natsui Kiyoshi,Watanabe Takao

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference25 articles.

1. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs;Ohno;Clin Pharmacokinet,2007

2. Grapefruit juice-drug interactions;Bailey;Br J Clin Pharmacol,1998

3. Prediction of the extent and variation of grapefruit juice–drug interactions from the pharmacokinetic profile in the absence of grapefruit juice;Kogure;Biopharm Drug Dispos,2014

4. Blonanserin: a review of its use in the management of schizophrenia;Deeks;CNS Drugs,2010

5. Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: a double-blind, parallel-group multicenter randomized trial;Li;J Psychiatr Res,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Novel therapies for nausea and vomiting in advanced illness and supportive cancer care;Palliative Care and Social Practice;2024-01

3. Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy;Journal of Clinical Psychopharmacology;2022-04-05

4. Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: A 52-week open-label study;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2022-03

5. Experience with Blonanserin Patch for Prevention of Nausea and Vomiting during the Initiation of Continuous Subcutaneous Injection of Hydromorphone Hydrochloride in Patients with End-stage Cancer Who are Difficult to Take Internal Medication in Palliative Care Unit;Palliative Care Research;2022